Aaja Residency Profile
Key Indicators
- Authorised Capital ₹ 9.50 M
as on 04-07-2024
- Paid Up Capital ₹ 6.30 M
as on 04-07-2024
- Company Age 28 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 31.79%
(FY 2023)
- Profit 181.25%
(FY 2023)
- Ebitda 313.92%
(FY 2023)
- Net Worth 3.81%
(FY 2023)
- Total Assets 7.34%
(FY 2023)
About Aaja Residency
The Corporate was formerly known as Aakash Finstocks Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 M and a paid-up capital of Rs 6.30 M, as per Ministry of Corporate Affairs (MCA) records.
Shreyasi Agrawal, Shalini Agarwal, Neel Gupta, and Three other members serve as directors at the Company.
- CIN/LLPIN
U67120MH1996PTC100455
- Company No.
100455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aaja Residency?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreyasi Agrawal  | Director | 19-Nov-2018 | Current |
| Shalini Agarwal | Director | 19-Nov-2018 | Current |
| Neel Gupta | Director | 25-May-2018 | Current |
| Neeta Gupta | Director | 25-May-2018 | Current |
| Rekha Kanodia | Director | 25-May-2018 | Current |
| Angooridevi Agrawal | Director | 06-Jun-2007 | Current |
Financial Performance of Aaja Residency.
Aaja Residency Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.79% increase. The company also saw a substantial improvement in profitability, with a 181.25% increase in profit. The company's net worth moved up by a moderate rise of 3.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aaja Residency?
In 2023, Aaja Residency had a promoter holding of 66.13% and a public holding of 33.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anthias Biopharma Private LimitedActive 6 years 30 daysShreyasi Agrawal and Shalini Agarwal are mutual person
- Aaja Hotel Private LimitedActive 23 years 6 months
Neel Gupta, Neeta Gupta and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aaja Residency?
Unlock and access historical data on people associated with Aaja Residency, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aaja Residency, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaja Residency's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
